Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway

Min Jung Kim1, Tae Hwa Lee, Sung Han Kim

  • 1Shinsegae Women's Hospital, Busan, Korea.

Insights

Triptolide induces programmed cell death (apoptosis) in human cervical cancer cells by activating caspases and affecting mitochondrial function. This natural compound also impacts key signaling pathways like Akt and Mcl-1.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Triptolide, derived from Tripterygium wilfordii Hook F, exhibits immunosuppressive and anti-inflammatory effects.
  • Cervical cancer remains a significant global health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the pro-apoptotic effects of triptolide in human cervical cancer cells.
  • To elucidate the underlying molecular mechanisms of triptolide-induced apoptosis.

Main Methods:

  • Human cervical cancer cells were treated with triptolide.
  • Assessed apoptosis markers including mitochondrial membrane potential and caspase activation.
  • Investigated the roles of Akt and Mcl-1 signaling pathways.

Main Results:

  • Triptolide induced apoptosis, evidenced by mitochondrial membrane potential loss and caspase processing (caspase-8, -9, -3) and PARP cleavage.
  • Apoptosis was caspase-dependent, as shown by inhibition with z-VAD-fmk.
  • Triptolide reduced Akt phosphorylation and Mcl-1 expression, effects modulated by LY294002 and Akt/Mcl-1 overexpression.

Conclusions:

  • Triptolide triggers caspase-dependent, mitochondria-mediated apoptosis in cervical cancer cells.
  • The mechanism involves negative regulation of Akt and Mcl-1 signaling pathways.
  • Triptolide shows potential as a therapeutic agent for cervical cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.